ArticleWorld journal of oncology2022

Precise Therapeutic Benefits and Underlying Mechanisms of Anlotinib Combined With Checkpoint Immunotherapy in Advanced Non-Small-Cell Lung Cancer.

Yi Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.